TY - JOUR
T1 - Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage
AU - Sleat, David E.
AU - Gin, Rosalie M.
AU - Sohar, Istvan
AU - Wisniewski, Krystyna
AU - Sklower-Brooks, Susan
AU - Pullarkat, Raju K.
AU - Palmer, David N.
AU - Lerner, Terry J.
AU - Boustany, Rose Mary
AU - Uldall, Peter
AU - Siakotos, Aristotle N.
AU - Donnelly, Robert J.
AU - Lobel, Peter
N1 - Funding Information:
We gratefully acknowledge the many parents and families and their respective physicians who have participated in this study. We would particularly like to thank Lance Johnston of the Batten Disease Support and Research Association for his help in enrolling subjects in this study. Other collaborators whom we wish to thank are Dr. Stefano Goldwurm (Clinica Pediatrica, Universita' di Milano, Fondazione Tettamanti, Ospedale San Gerardo Monza, Milan), Dr. Petra Krebs (Institut fuer Humangenetik, Magdeburg, Germany), Dr. Fuki Hisama (Yale University School of Medicine, New Haven, Connecticut), Drs. Cheryl Greenberg and Louise Dilling (Health Sciences Center, Winnipeg, Canada), and Dr. Elizabeth Berry-Kravis (Rush-Presbyterian-St. Luke's Medical Center, Chicago). We thank the Laboratorio di diagnosi pre e postnatale malattie metaboliche (Istituto G. Gaslini, Genova, Italy) for providing us with specimens from the collection “Cell lines and DNA bank from patients affected by genetic disease,” supported by Telethon grants (project C. 20); the National Institute of General Medical Sciences Human Genetic Mutant Cell Repository at the Corriell Institute for Medical Research (Camden, New Jersey); the McGill University Repository for Mutant Human Cell Strains (Toronto, Canada); and the Batten Disease Lymphocyte Cell Bank at the Indiana University School of Medicine. Some brain samples were obtained from the National Neurological Research Specimen Bank, Veterans Administration Greater Los Angeles Health Care System (West Los Angeles, California), which is sponsored by NINDS/NIMH, the National Multiple Sclerosis Society, the Veterans Administration Greater Los Angeles Healthcare System, and the Veterans Health Services and Research Administration ofthe Department of Veterans Affairs. This work was supported by the Children's Brain Disease Foundation and by National Institutes of Health grants DK45992 and NS37918 (to P.L.).
PY - 1999
Y1 - 1999
N2 - The late-infantile form of neuronal ceroid lipofuscinosis (LINCL) is a progressive and ultimately fatal neurodegenerative disease of childhood. The defective gene in this hereditary disorder, CLN2, encodes a recently identified lysosomal pepstatin-insensitive acid protease. To better understand the molecular pathology of LINCL, we conducted a genetic survey of CLN2 in 74 LINCL families. In 14 patients, CLN2 protease activities were normal and no mutations were identified, suggesting other forms of NCL. Both pathogenic alleles were identified in 57 of the other 60 LINCL families studied. In total, 24 mutations were associated with LINCL, comprising six splice-junction mutations, 11 missense mutations, 3 nonsense mutations, 3 small deletions, and 1 single-nucleotide insertion. Two mutations were particularly common: an intronic G→C transversion in the invariant AG of a 3' splice junction, found in 38 of 115 alleles, and a C→T transition in 32 of 115 alleles, which prematurely terminates translation at amino acid 208 of 563. An Arg→His substitution was identified, which was associated with a late age at onset and protracted clinical phenotype, in a number of other patients originally diagnosed with juvenile NCL.
AB - The late-infantile form of neuronal ceroid lipofuscinosis (LINCL) is a progressive and ultimately fatal neurodegenerative disease of childhood. The defective gene in this hereditary disorder, CLN2, encodes a recently identified lysosomal pepstatin-insensitive acid protease. To better understand the molecular pathology of LINCL, we conducted a genetic survey of CLN2 in 74 LINCL families. In 14 patients, CLN2 protease activities were normal and no mutations were identified, suggesting other forms of NCL. Both pathogenic alleles were identified in 57 of the other 60 LINCL families studied. In total, 24 mutations were associated with LINCL, comprising six splice-junction mutations, 11 missense mutations, 3 nonsense mutations, 3 small deletions, and 1 single-nucleotide insertion. Two mutations were particularly common: an intronic G→C transversion in the invariant AG of a 3' splice junction, found in 38 of 115 alleles, and a C→T transition in 32 of 115 alleles, which prematurely terminates translation at amino acid 208 of 563. An Arg→His substitution was identified, which was associated with a late age at onset and protracted clinical phenotype, in a number of other patients originally diagnosed with juvenile NCL.
UR - http://www.scopus.com/inward/record.url?scp=0033365201&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033365201&partnerID=8YFLogxK
U2 - 10.1086/302427
DO - 10.1086/302427
M3 - Article
C2 - 10330339
AN - SCOPUS:0033365201
SN - 0002-9297
VL - 64
SP - 1511
EP - 1523
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 6
ER -